Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis

American Journal of Health-System Pharmacy

Volumn 59, Issue 15, 2002, Pages 1437-1440

  Eyrich, Heather ^a   Walton, Ted ^a   Macon, Edwin J ^a   Howe, Andrew ^a  

^a GRADY HEALTH SYSTEM   (United States)

Author keywords

Alteplase; Catheters; Dialysis; Thrombolytic agents; Thrombosis; Urokinase

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CATHETER; CLINICAL ARTICLE; DIALYSIS; DRUG COST; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

EID: 0036684535     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.15.1437     Document Type: Article

References (16)

1. The use of alteplase (t-PA) for the management of thrombotic catheter dysfunction
2. Continuous infusion of low-dose urokinnase in the treatment of central venous catheter thrombosis in infants and children
3. Obstructed central venous catheters: Restoring function with a 12-hour infusion of low-dose urokinase
4. Thrombosed central venous catheters: Restoring function with a 6-hour urokinase infusion after failure of bolus urokinase
5. Efficacy of thrombolytic therapy for occlusion of long-term catheters
6. The use of tissue plaminogen activator to declot arteriovenous accesses in hemodialysis patients
7. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters
8. Use of tissue plasminogen activator for reopening of clotted dialysis catheters
9. Local thrombolysis with recombinant tissue plasminogen activator for thrombosed vascular access in hemodialysis patients
10. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices
11. Bio-activity of cryopreserved alteplase solutions
12. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blinded, randomized trial
13. NKF-K/DOQI clinical practice guidelines for vascular access: Update 2000